No Data
No Data
No Data
No Data
No Data
X4 Pharmaceuticals, Inc.'s (NASDAQ:XFOR) Market Cap Decline of US$42m May Not Have as Much of an Impact on Institutional Owners After a Year of 7.0% Returns
Yahoo FinanceApr 11 10:15 ET
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, April 02, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (NASDAQ:XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective on April 1, 2024,
GlobeNewswireApr 2 16:05 ET
X4 Pharmaceuticals Updates Corporate Presentation Online
TipRanksApr 1 09:32 ET
X4 Pharmaceuticals to Participate in Upcoming April Investor Conferences
BOSTON, April 01, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that managemen
X4 PharmicalsApr 1 00:00 ET
X4 Pharmaceuticals on the Brink: The Race Against Nasdaq Delisting and Investor Confidence
TipRanksMar 23 02:01 ET
Express News | HC Wainwright & Co. Reiterates Buy on X4 Pharmaceuticals, Maintains $3 Price Target
Moomoo 24/7Mar 22 14:54 ET
Joy Boy Myth : several days later good news might come related FDA... hope it's approval...
No Data
No Data